Codexis (CDXS) Change in Acquisitions & Divestments (2010 - 2026)
Codexis' (CDXS) quarterly Change in Acquisitions & Divestments came in at $19.1 million in Q1 2026, down 18.24% year-on-year from $23.3 million in Q1 2025, and down 11.21% quarter-over-quarter from $21.5 million in Q4 2025.
Codexis (CDXS) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Codexis' Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $19.1 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments fell 18.24% year-over-year to $19.1 million in Q1 2026; TTM through Mar 2026 was $80.9 million, a 219.34% increase from a year earlier, with the FY2025 full-year figure at $85.1 million, up 4214.55% from the prior year.
- Change in Acquisitions & Divestments eased to $19.1 million in Q1 2026 per CDXS's latest filing, from $21.5 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $24.3 million in Q3 2025 and bottomed at -$17.0 million in Q4 2024.
- The 3-year median for Change in Acquisitions & Divestments is $17.5 million (2024), against an average of $13.3 million.
- Across the five-year window, Change in Acquisitions & Divestments surged 433.33% in 2025 and decreased 18.24% in 2026, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at -$17.0 million in 2024, then jumped by 226.27% to $21.5 million in 2025, then fell by 11.21% to $19.1 million in 2026.
- Per Business Quant, the three latest CDXS Change in Acquisitions & Divestments figures stand at $19.1 million (Q1 2026), $21.5 million (Q4 2025), and $24.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Codexis | 140.24 Mn | 75.10 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.09 Mn |
| Mar 31, 2026 | 19.09 Mn |
| Dec 31, 2025 | 21.50 Mn |
| Dec 31, 2025 | 21.50 Mn |
| Sep 30, 2025 | 24.28 Mn |
| Sep 30, 2025 | 24.28 Mn |
| Jun 30, 2025 | 16.00 Mn |
| Jun 30, 2025 | 16.00 Mn |
| Mar 31, 2025 | 23.35 Mn |
| Mar 31, 2025 | 23.35 Mn |
| Dec 31, 2024 | -17.03 Mn |
| Dec 31, 2024 | -17.03 Mn |
| Sep 30, 2024 | 16.00 Mn |
| Sep 30, 2024 | 16.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Sep 30, 2019 | 100,000.00 |
| Sep 30, 2019 | 100,000.00 |
| Jun 30, 2014 | 1.00 Mn |
| Jun 30, 2014 | 1.00 Mn |